Drug Type Biological products  | 
Synonyms-  | 
Target  | 
Action modulators  | 
Mechanism CD37 modulators(Leukocyte antigen CD37 modulators)  | 
Therapeutic Areas  | 
Active Indication  | 
Inactive Indication-  | 
Originator Organization  | 
Active Organization  | 
Inactive Organization-  | 
License Organization-  | 
Drug Highest PhasePreclinical  | 
First Approval Date-  | 
Regulation-  | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Burkitt Lymphoma | Preclinical | Norway   | 11 Dec 2022 | 





